首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2423553篇
  免费   201732篇
  国内免费   4332篇
耳鼻咽喉   34788篇
儿科学   74392篇
妇产科学   64006篇
基础医学   343130篇
口腔科学   69099篇
临床医学   220382篇
内科学   478106篇
皮肤病学   48808篇
神经病学   206274篇
特种医学   97908篇
外国民族医学   892篇
外科学   366227篇
综合类   56498篇
现状与发展   2篇
一般理论   1039篇
预防医学   197047篇
眼科学   56350篇
药学   180975篇
  4篇
中国医学   4496篇
肿瘤学   129194篇
  2018年   25379篇
  2017年   19754篇
  2016年   21656篇
  2015年   24503篇
  2014年   35283篇
  2013年   53003篇
  2012年   72108篇
  2011年   75661篇
  2010年   44252篇
  2009年   42700篇
  2008年   71636篇
  2007年   76057篇
  2006年   76812篇
  2005年   74648篇
  2004年   71601篇
  2003年   69085篇
  2002年   68183篇
  2001年   113787篇
  2000年   117812篇
  1999年   99493篇
  1998年   28535篇
  1997年   26049篇
  1996年   25940篇
  1995年   25041篇
  1994年   23571篇
  1993年   21916篇
  1992年   80196篇
  1991年   77092篇
  1990年   74255篇
  1989年   71486篇
  1988年   66419篇
  1987年   65350篇
  1986年   61863篇
  1985年   58921篇
  1984年   44620篇
  1983年   38036篇
  1982年   23097篇
  1981年   20517篇
  1979年   41637篇
  1978年   29223篇
  1977年   24524篇
  1976年   22962篇
  1975年   24110篇
  1974年   29806篇
  1973年   28219篇
  1972年   26392篇
  1971年   24336篇
  1970年   22889篇
  1969年   21220篇
  1968年   19261篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.

Objective

Comparative survival between neoadjuvant chemotherapy and adjuvant chemotherapy for patients with cT2-4N0-1M0 non–small cell lung cancer has not been extensively studied.

Methods

Patients with cT2-4N0-1M0 non–small cell lung cancer who received platinum-based chemotherapy were retrospectively identified. Exclusion criteria included stage IV disease, induction radiotherapy, and targeted therapy. The primary end point was disease-free survival. Secondary end points were overall survival, chemotherapy tolerance, and ability of Response Evaluation Criteria In Solid Tumors response to predict survival. Survival was estimated using the Kaplan–Meier method, compared using the log-rank test and Cox proportional hazards models, and stratified using matched pairs after propensity score matching.

Results

In total, 330 patients met the inclusion criteria (n = 92/group after propensity-score matching; median follow-up, 42 months). Five-year disease-free survival was 49% (95% confidence interval, 39-61) for neoadjuvant chemotherapy versus 48% (95% confidence interval, 38-61) for adjuvant chemotherapy (P = .70). On multivariable analysis, disease-free survival was not associated with neoadjuvant chemotherapy or adjuvant chemotherapy (hazard ratio, 1.1; 95% confidence interval, 0.64-1.90; P = .737), nor was overall survival (hazard ratio, 1.21; 95% confidence interval, 0.63-2.30; P = .572). The neoadjuvant chemotherapy group was more likely to receive full doses and cycles of chemotherapy (P = .014/0.005) and had fewer grade 3 or greater toxicities (P = .001). Response Evaluation Criteria In Solid Tumors response to neoadjuvant chemotherapy was associated with disease-free survival (P = .035); 15% of patients receiving neoadjuvant chemotherapy (14/92) had a major pathologic response.

Conclusions

Timing of chemotherapy, before or after surgery, is not associated with an improvement in overall or disease-free survival among patients with cT2-4N0-1M0 non–small cell lung cancer who undergo complete surgical resection.  相似文献   
42.
43.
44.
45.
46.
47.
48.
Acne vulgaris (acne) is a chronic inflammatory disease of the sebaceous gland, characterized by follicular hyperkeratinization, excessive colonization by Propionibacterium acnes (Pacnes) as well as immune reactions and inflammation. Despite an armamentarium of topical treatments available including benzoyl peroxide, retinoids and azelaic acid, topical antibiotics in monotherapies, especially erythromycin and clindamycin, are still used in Europe to treat acne. This intensive use led to antimicrobial‐resistant P. acnes and staphylococci strains becoming one of the main health issues worldwide. This is an update on the current topical acne treatments available in Europe, their mechanism of action, their potential to induce antimicrobial resistance and their clinical efficacy and safety.  相似文献   
49.
50.
Dosage form is a mean used for the delivery of drug to a living body. In order to get the desired effect the drug should be delivered to its site of action at such rate and concentration to achieve the maximum therapeutic effect and minimum adverse effect. Since oral route is still widely accepted route but having a common drawback of difficulty in swallowing of tablets and capsules. Therefore a lot of research has been done on novel drug delivery systems. This review is about oral dispersible tablets a novel approach in drug delivery systems that are now a day''s more focused in formulation world, and laid a new path that, helped the patients to build their compliance level with the therapy, also reduced the cost and ease the administration especially in case of pediatrics and geriatrics. Quick absorption, rapid onset of action and reduction in drug loss properties are the basic advantages of this dosage form.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号